Form 4: Bios Equity Entities Report Changes in Actuate Therapeutics Ownership Following IPO
SEC Form 4
Following Actuate Therapeutics' IPO, Bios Equity and related entities report changes in beneficial ownership, including conversions of preferred stock and cashless exercises of warrants.
Summary
- Bios Equity COF, LP, Bios Clinical Opportunity Fund, LP, and BP Directors, LP, along with related entities, filed Form 4s detailing changes in their beneficial ownership of Actuate Therapeutics, Inc. common stock.
- These changes occurred following Actuate Therapeutics' initial public offering (IPO).
- The filings reflect the conversion of convertible notes and preferred stock into common stock upon the closing of the IPO.
- Warrants to purchase common stock were also automatically exercised on a cashless basis in connection with the IPO.
- The reporting persons may be deemed 'director by deputization' due to Aaron G.L. Fletcher's position as a director of the Issuer.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing ownership changes after an IPO. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
Form 4 filings are standard practice following significant events like IPOs, providing transparency into the ownership changes of company insiders and major shareholders.
Stakeholder Impact
- Shareholders are informed about the changes in ownership structure following the IPO.
- The conversion of preferred stock and exercise of warrants dilutes existing shareholders' ownership.
Key Dates
| Date | Description |
|---|---|
| 08/12/2024 | Date of earliest transaction; stock options granted to Aaron G.L. Fletcher; cashless exercise of warrants in connection with IPO. |
| 08/14/2024 | Date of transactions including conversions of preferred stock and notes, warrant exercises, and sales of common stock. |
| 08/12/2025 | Vesting date for stock options granted to Aaron G.L. Fletcher. |
| 08/14/2026 | Two-year anniversary of the first closing of the Issuer's IPO; one of the potential expiration dates for certain warrants. |
| 09/07/2028 | Potential expiration date for certain warrants. |
| 04/29/2033 | Expiration date for stock options held by BP Directors, LP. |
| 08/12/2034 | Expiration date for stock options granted to Aaron G.L. Fletcher. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.